Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of the Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma

NCT00715793 is registered in ClinicalTrials.gov with Hussein Tawbi as lead sponsor.

NCT NCT00715793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00715793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of the Combination of Decitabine and Temozolomide in the Treatment of Patients With Metastatic Melanoma
Lead sponsor
Hussein Tawbi
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2008
Completion date
August 31, 2015
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma